- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
More Providers, Insurers Showing Appetite for Narrow Networks
Providers and insurers across the country are partnering to launch narrow-network plans even as controversy continues over whether these plans offer adequate provider access for consumers.
A new health plan collaboration in Wisconsin between a hospital system and an insurer is the latest sign that providers and insurers are betting on narrow networks even as controversy continues over whether these plans offer adequate provider access for consumers.
Aspirus, a not-for-profit health system based in Wausau, Wisconsin, and not-for-profit health insurer Arise Health Plan this week unveiled their co-branded health plan for individuals and small businesses with fewer than 50 workers, said Brett Davis, vice president of provider relations at WPS Health Insurance, Arise's parent company. WPS covers about 250,000 people across the state.
Consumers and employer groups that purchase the plan will receive discounted in-network care at Aspirus' 6 hospitals and from any physicians employed by Aspirus or doctors who contract with the system. Executives said the plan will have “affordable” monthly premiums but declined to be more specific. They declined to say whether the plan will be offered on Wisconsin's insurance exchange under the Patient Protection and Affordable Care Act.
Read the full story at Modern Healthcare: http://bit.ly/1oe7puY
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
